Minostad (Minocycline Hydrochloride Dihydrate)

Minocycline binds to the bacterial 30S ribosomal subunit, blocking the addition of aminoacyl‑tRNA to the growing peptide chain. This inhibition of protein synthesis stops bacterial growth, providing a bacteriostatic effect against a broad spectrum of Gram‑positive and Gram‑negative bacteria.

The exact dose of Minostad is determined by the prescribing clinician based on the specific infection, patient age, weight, renal and hepatic function, and local antimicrobial guidelines. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for minocycline in pregnancy are limited, and the drug is generally avoided unless the potential benefit justifies the risk to the fetus. It is also excreted in breast milk, so breastfeeding mothers should consult their healthcare provider before using Minostad.

To order Minostad, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Minostad (minocycline) offers a longer half‑life and better tissue penetration than doxycycline, allowing once‑ or twice‑daily dosing for many infections. It also has a broader spectrum against certain resistant strains, but it may have a higher incidence of vestibular side effects such as dizziness.

Minostad should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture and direct sunlight to maintain stability and potency throughout its shelf life.

Minostad is taken orally, usually with a full glass of water. It can be taken with or without food, but patients should avoid concurrent intake of antacids containing aluminium or magnesium, as these can reduce absorption.

Serious adverse reactions include drug‑induced hepatitis, Stevens‑Johnson syndrome, severe allergic reactions such as anaphylaxis, intracranial hypertension, autoimmune hemolytic anemia, and renal toxicity. Patients should seek immediate medical attention if they experience rash, fever, visual changes, or signs of liver dysfunction.

Minostad is contraindicated in individuals with known hypersensitivity to minocycline or other tetracyclines, children younger than eight years, pregnant women unless clearly indicated, and patients with severe hepatic or renal impairment without dose adjustment. Caution is also advised for those with a history of autoimmune disorders.